REGENERON PHARMACEUTICALS, INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- REGENERON PHARMACEUTICALS, INC. treasury stock, shares, acquired for the quarter ending 2026-06-30 was 1.70M shares, a 10.53% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. treasury stock, shares, acquired for the quarter ending 2026-03-31 was 1.00M shares, a 33.33% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. treasury stock, shares, acquired for the quarter ending 2025-09-30 was 1.10M shares, a 83.33% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. treasury stock, shares, acquired for the quarter ending 2025-06-30 was 1.90M shares, a 216.67% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. treasury stock, shares, acquired for fiscal 2019 was 722.60K shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2026-06-30 | 1.70M shares 10-Q · filed 2026-07-30 | |
| 2026-03-31 | 1.00M shares 10-Q · filed 2026-04-29 | |
| 2025-09-30 | 1.10M shares 10-Q · filed 2025-10-28 | |
| 2025-06-30 | 1.90M shares 10-Q · filed 2026-07-30 | |
| 2025-03-31 | 1.50M shares 10-Q · filed 2026-04-29 | |
| 2024-09-30 | 600.00K shares 10-Q · filed 2025-10-28 | |
| 2024-06-30 | 600.00K shares 10-Q · filed 2025-08-01 | |
| 2024-03-31 | 300.00K shares 10-Q · filed 2025-04-29 | |
| 2023-09-30 | 700.00K shares 10-Q · filed 2024-10-31 | |
| 2023-06-30 | 1.00M shares 10-Q · filed 2024-08-01 | |
| 2023-03-31 | 900.00K shares 10-Q · filed 2024-05-02 | |
| 2022-09-30 | 1.50M shares 10-Q · filed 2023-11-02 | |
| 2022-06-30 | 700.00K shares 10-Q · filed 2023-08-03 | |
| 2022-03-31 | 600.00K shares 10-Q · filed 2023-05-04 | |
| 2021-09-30 | 300.00K shares 10-Q · filed 2022-11-03 | |
| 2021-06-30 | 600.00K shares 10-Q · filed 2022-08-03 | |
| 2020-09-30 | 200.00K shares 10-Q · filed 2021-11-04 | |
| 2020-06-30 | 0.00 shares 10-Q · filed 2021-08-05 | |
| 2019-12-31 | 722.60K shares 10-K · filed 2020-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |